Alexandra Guadagno

World Lung Cancer Day 2019: Facts & Figures

August 01, 2019

The earlier lung cancer is detected, the better chance a person has of surviving the disease. Knowing the risk factors and statistics will help you to understand how you can minimize your possibility of developing the disease.

FDA Asks Allergan to Voluntarily Recall Breast Implants to Protect Against Rare Cancer

July 24, 2019

The Food and Drug Administration has requested that the manufacturer voluntarily recall certain breast implants and tissue expanders from the market to protect women from risks such as breast implant-associated anaplastic large cell lymphoma.

Addition of Darzalex to Chemotherapy Shows Promise in Myeloma

July 09, 2019

The use of Darzalex in combination with Revlimid, Velcade and Ozurdex demonstrated a higher percentage of stringent complete responses among transplant eligible, newly diagnosed patients with multiple myeloma.

FDA Approves Zirabev, an Avastin Biosimilar, for Five Cancer Types

June 28, 2019

The FDA has approved Zirabev, a biosimilar to Avastin, for the treatment of five types of cancer: colorectal cancer; non-small cell lung cancer; glioblastoma; metastatic renal cell carcinoma; and persistent, recurrent or metastatic cervical cancer.

Opdivo Plus Radiation Fails to Prolong Survival in Subtype of Glioblastoma

May 09, 2019

The phase 3 CheckMate 498 trial, designed to compare Opdivo with Temodal for the treatment of patients with newly diagnosed O6-methylguanine-DNA methyltransferase (MGMT)-unmethylated glioblastoma multiforme failed to meet its primary endpoint of increasing overall survival.